Naloxone hydrochloride /ml
Phase 1Small molecule
Naloxone hydrochloride /ml is one of 5 small molecule programs targeting Ocular pain. It is currently in Phase 1.
1
Indications
3
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
8 competitors in Ocular Pain
#DrugCompanyPhaseTrials
1Toradol
RocheApproved
Dexycu
EEyePoint Pharmaceuticals, Inc.
Phase 3
Lotemax
BBausch & Lomb Incorporated
Phase 1
SYL1001
SSylentis, S.A.
Phase 2
Naloxone hydrochloride /ml
PPouya Azar
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Naloxone hydrochloride /ml. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 1[1]
- Company
- PPouya Azar